Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Evidence-Based Mental Health
|
October 27, 2009
Review: limited evidence that adding a second antipsychotic improves clozapine treatment in schizophrenia
Azizah Attard, Fiona Gaughran
CNS Drugs
|
June 7, 2012
Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?
Azizah Attard, David M Taylor
BMC Psychiatry
|
October 8, 2013
Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study
Rani Samuel, Azizah Attard, Marinos Kyriakopoulos
CNS Drugs
|
July 8, 2008
Delirium and its treatment
Azizah Attard, Gopinath Ranjith, David Taylor
BMC Psychiatry
|
September 9, 2010
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report
Sachin S Patel, Azizah Attard, Pamela Jacobsen, et al.
BMC Psychiatry
|
September 9, 2010
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature
Sachin S Patel, Azizah Attard, Pamela Jacobsen, et al.
Therapeutic Advances in Psychopharmacology
|
July 25, 2022
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years' experience at a UK high-secure hospital
Azizah Attard, John Wakelam, Josephine Broyd, et al.
Therapeutic Advances in Psychopharmacology
|
February 3, 2022
Brugada syndrome: should we be screening patients before prescribing psychotropic medication?
Azizah Attard, Claire Stanniland, Stephen Attard, et al.
The Primary Care Companion for CNS Disorders
|
February 10, 2023
Management of Psychiatric Conditions in Patients With Comorbid Postural Orthostatic Tachycardia Syndrome: A Literature Review and Case Vignette
Azizah Attard, Stephen Attard, Claire Stanniland, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Evidence-Based Mental Health
|
October 27, 2009
Review: limited evidence that adding a second antipsychotic improves clozapine treatment in schizophrenia
Azizah Attard, Fiona Gaughran
CNS Drugs
|
June 7, 2012
Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?
Azizah Attard, David M Taylor
BMC Psychiatry
|
October 8, 2013
Mental state deterioration after switching from brand-name to generic olanzapine in an adolescent with bipolar affective disorder, autism and intellectual disability: a case study
Rani Samuel, Azizah Attard, Marinos Kyriakopoulos
CNS Drugs
|
July 8, 2008
Delirium and its treatment
Azizah Attard, Gopinath Ranjith, David Taylor
BMC Psychiatry
|
September 9, 2010
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report
Sachin S Patel, Azizah Attard, Pamela Jacobsen, et al.
BMC Psychiatry
|
September 9, 2010
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a review of the literature
Sachin S Patel, Azizah Attard, Pamela Jacobsen, et al.
Therapeutic Advances in Psychopharmacology
|
July 25, 2022
Olanzapine long-acting injection, discontinuation rates and reasons for discontinuation: 10 years' experience at a UK high-secure hospital
Azizah Attard, John Wakelam, Josephine Broyd, et al.
Therapeutic Advances in Psychopharmacology
|
February 3, 2022
Brugada syndrome: should we be screening patients before prescribing psychotropic medication?
Azizah Attard, Claire Stanniland, Stephen Attard, et al.
The Primary Care Companion for CNS Disorders
|
February 10, 2023
Management of Psychiatric Conditions in Patients With Comorbid Postural Orthostatic Tachycardia Syndrome: A Literature Review and Case Vignette
Azizah Attard, Stephen Attard, Claire Stanniland, et al.
Page
of 1